Would like to see the results to date compared to nivolumab monotherapy in a similar subset of patients. If no better then Veyonda is worthless. Anyone know?
Seems like the result isn't that exciting given the company didn't even bother to comment.
I actually can't believe that! Our last remaining clinical trial, with no more clinical trials planned for probably 5 years, and the company didn't even bother to comment or summarise the results! Disgusting behavior.
